Dark

Check out our API

TARO
Taro Pharmaceutical Industries Ltd.
stock NYSE

Inactive

Jun 21, 2024

42.97USD0.000%(0.00)233,579

Pre-market

0.00USD-100.000%(-42.97)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 31, 2022

07:49AM EST 10 Biggest Price Target Changes For Monday Benzinga

06:47AM EST HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $73 Benzinga

Jan 28, 2022

08:21AM EST The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron Benzinga

03:51AM EST Taro Pharmaceutical: Q3 Earnings Insights Benzinga

Jan 27, 2022

05:06PM EST Taro Pharmaceutical Indus Q3 EPS $0.70 Down From $0.86 YoY, Sales $139.00M Miss $142.22M Estimate Benzinga

05:00PM EST Taro Provides Results for December 31, 2021 Business Wire

07:58AM EST The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study Benzinga

04:37AM EST Earnings Scheduled For January 27, 2022 Benzinga

Jan 20, 2022

08:45PM EST Taro to Announce Third Quarter Results on January 27, 2022 Business Wire

Jan 18, 2022

09:39AM EST HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $75 Benzinga

Dec 31, 2021

09:04AM EST Taro Pharmaceuticals U.S.A., Inc. has recalled one lot of corticosteroid Clobetasol Propionate in the form of ointment for the potential presence of Ralstonia pickettii bacteria, the U.S. Food and Drug Administration or FDA said in a statement. RTTNews

Dec 2, 2021

07:51AM EST The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance Benzinga

Dec 1, 2021

05:14PM EST Taro Appoints William Coote As VP, CFO And Chief Accounting Officer RTTNews

05:07PM EST Taro Pharma Names William Coote CFO, Chief Accounting Officer Benzinga

05:05PM EST Taro Appoints New Chief Financial Officer Business Wire

Nov 5, 2021

09:31AM EDT Taro Pharmaceutical Industries Announced Unit Enters Into Settlement Agreement in in Re Generic Pharmaceuticals Pricing Antitrust Litigation in 6K Filing Benzinga

Oct 28, 2021

05:48PM EDT Taro Pharmaceutical Industries Ltd (TARO) reported a profit for second quarter that declined from last year. RTTNews

05:34PM EDT Taro Pharmaceutical Indus Q2 Adj. EPS $0.66 Down From $1.18 YoY, Sales $132.00M Down From $142.84M YoY Benzinga

05:15PM EDT Taro Provides Results for September 30, 2021 Business Wire

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 21, 2021

01:01PM EDT Taro to Announce Second Quarter Results on October 28, 2021 Business Wire

Jul 28, 2021

06:25AM EDT HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Raises Price Target to $82 Benzinga

Jul 27, 2021

07:28PM EDT Taro Provides Results for Quarter Ended June 30, 2021 Business Wire

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

04:03AM EDT Earnings Scheduled For July 27, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 20, 2021

09:05PM EDT Taro to Announce First Quarter Results on July 27, 2021 Business Wire

Jul 15, 2021

06:01AM EDT A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Economic Data Benzinga

Jul 14, 2021

05:55PM EDT Taro Announces Resignation of Chief Financial Officer Benzinga

Jun 18, 2021

10:00AM EDT Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021 Business Wire

Jun 2, 2021

06:32AM EDT HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $80 Benzinga

May 19, 2021

05:46PM EDT Taro Pharmaceutical Indus Q4 EPS $(0.78) Down From $1.42 YoY, Sales $148.30M Beat $147.33 Estimate Benzinga

05:30PM EDT Taro Provides Results for the Year Ended March 31, 2021 Business Wire

04:02AM EDT Earnings Scheduled For May 19, 2021 Benzinga

May 18, 2021

10:08AM EDT Earnings Preview for Taro Pharmaceutical Indus Benzinga

May 12, 2021

05:58PM EDT Taro to Announce Full Year Results on May 19, 2021 Business Wire

Feb 1, 2021

06:29AM EST HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Raises Price Target to $81 Benzinga

Jan 27, 2021

05:49PM EST Taro Pharmaceutical Indus Q3 EPS $0.86 Misses $1.01 Estimate, Sales $140.10M Miss $152.63M Estimate Benzinga

05:46PM EST Taro Provides Results for December 31, 2020 Business Wire

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

04:09AM EST Earnings Scheduled For January 27, 2021 Benzinga

Jan 23, 2021

09:14AM EST The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More Benzinga

Jan 20, 2021

08:28PM EST Taro to Announce Third Quarter Results on January 27, 2021 Business Wire

Nov 23, 2020

06:29AM EST HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $80 Benzinga

Oct 28, 2020

05:15PM EDT Taro Provides Results for September 30, 2020 Business Wire

Oct 21, 2020

06:44PM EDT Taro to Announce Second Quarter Results on October 28, 2020 Business Wire

Sep 28, 2020

01:23PM EDT Taro Launches Specialty Generic Deferiprone Tablets, 500mg In The U.S. RTTNews

Aug 26, 2020

03:36PM EDT Teva Analyst Estimates $1B In Price-Fixing Liability Following DOJ Indictment Benzinga

Aug 25, 2020

10:45PM EDT Teva Pharmaceuticals USA Inc., a unit of Teva Pharmaceutical Industries Ltd. (TEVA), was charged with three counts of conspiring to fix prices, rig bids, and allocate customers for generic drugs, the U.S. Department of Justice said in a statement on Tuesday. RTTNews

10:43PM EDT US Indicts Teva Pharmaceutical In Generic Drug Price-Fixing Case Benzinga

Jul 29, 2020

05:03PM EDT Taro Pharmaceutical Indus Q1 EPS $(11.37) Down From $1.72 YoY, Sales $117.63M Miss $158.35M Estimate Benzinga

05:03PM EDT Taro Pharmaceutical Indus Q1 Sales $117.60M Miss $158.35M Estimate Benzinga

05:00PM EDT Taro Provides Results for Quarter Ended June 30, 2020 Business Wire

04:04AM EDT Earnings Scheduled For July 29, 2020 Benzinga

Jul 27, 2020

06:46AM EDT HC Wainwright & Co. Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $82 Benzinga

Jul 23, 2020

04:33PM EDT Taro Says Has Resolved All Cases Involving Co. In Connection With In DOJ Antitrust Investigations Benzinga

04:32PM EDT Taro Achieves Global Resolution of DOJ Antitrust Investigations Business Wire

Jul 22, 2020

02:37PM EDT Taro to Announce First Quarter Results on July 29, 2020 Business Wire

Share